Significant differences were observed in age, diabetes history, history of liver cancer, history of hepatic artery embolization, recent antibiotic exposure, invasive procedures in the last 2 weeks, APACHE II Scoring, and ALB, SAA and BLA levels. The gene discussed is ALB; the disease is diabetes mellitus.